ERBB Stock Quote American Green Cannabis Reserve

Author

Reads 324

Laptops on a desk displaying stock market charts and financial documents.
Credit: pexels.com, Laptops on a desk displaying stock market charts and financial documents.

American Green Cannabis Reserve is a cannabis company that has a stock quote under the ticker symbol ERBB. ERBB is a relatively new stock, having been listed on the OTCQB exchange in 2020. The company is focused on the cultivation and sale of cannabis products.

The ERBB stock quote has been trading at around $0.10 per share, with a market capitalization of around $10 million. This is a relatively small market cap compared to other cannabis companies. The company's stock has been volatile, with a high of $0.20 and a low of $0.05 in the past year.

American Green Cannabis Reserve has a presence in several states, including California and Nevada. The company has plans to expand its operations to other states in the near future.

Curious to learn more? Check out: Pbi Stock Quote

Green Launches Premium Branded Cannabis Reserve in Arizona

American Green (ERBB) has launched its own premium cannabis flower, branded as "Private Reserve" in Arizona. This product is being sold at TruMed dispensary and plans to be marketed across over 70 dispensaries in the state.

Credit: youtube.com, ERBB - American Green

The cannabis is cultivated at their Sweet Virginia facility and is positioned to enhance sales and brand awareness. American Green emphasizes quality through a hand-selection and slow-drying process to preserve natural terpenes and flavors.

Future expansion includes the Cypress Chill facility aimed at optimizing production. This facility is expected to generate over $15 million in annual revenue, enhancing financial benefits compared to leasing.

The company has also signed a non-binding letter of intent with a private equity firm for $12 million to fund the completion of its 'Cypress Chill' grow building.

ERBB Data

The ERBB gene is associated with a family of receptor tyrosine kinases, including ERBB1, ERBB2, ERBB3, and ERBB4.

ERBB2 is the most commonly studied member of this family, particularly in the context of breast cancer.

ERBB2 amplification is found in about 20-30% of breast cancer cases.

Joan Lowe-Schiller

Assigning Editor

Joan Lowe-Schiller serves as an Assigning Editor, overseeing a diverse range of architectural and design content. Her expertise lies in Brazilian architecture, a passion that has led to in-depth coverage of the region's innovative structures and cultural influences. Under her guidance, the publication has expanded its reach, offering readers a deeper understanding of the architectural landscape in Brazil.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.